berberine vs. glp-1 is a potential alternative for metformin with good regulatory effect on lipids in treating metabolic diseases Exploring the GLP-1 Pathway and

The compound also downregulates microphthalmia-associated transcription factor (MITF) expression, which decreases both tyrosinase expression and melanocyte proliferation

10.1016/j.lfs.2017.08.019 23 EssickE

GLP-1 agonists Market Access and Reimbursement This section will include insights around the standard HTA pricing, recent reformations in 2024 and modifications in reimbursement process in the 7MM

It has also been shown to have superior bioavailability, which means it is easily absorbed and utilised by the body

Wen S, Arakawa H, Tamai I

Some indicate systemic or vascular conditions that require medical attention, not cosmetic correction